{"id":"https://openalex.org/W2994912142","doi":"https://doi.org/10.3390/cells9010037","title":"Anti-NASH Drug Development Hitches a Lift on PPAR Agonism","display_name":"Anti-NASH Drug Development Hitches a Lift on PPAR Agonism","alternate_titles":[],"publication_year":2019,"publication_date":"2019-12-21","ids":{"openalex":"https://openalex.org/W2994912142","doi":"https://doi.org/10.3390/cells9010037","mag":"2994912142","pmid":"https://pubmed.ncbi.nlm.nih.gov/31877771","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7016963"},"language":"en","primary_location":{"id":"doi:10.3390/cells9010037","doi":"https://doi.org/10.3390/cells9010037","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cells9010037","pdf_url":"https://www.mdpi.com/2073-4409/9/1/37/pdf?version=1577526275","source":{"id":"https://openalex.org/S2736626452","display_name":"Cells","issn_l":"2073-4409","issn":["2073-4409"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cells","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2994912142"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2073-4409/9/1/37/pdf?version=1577526275","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080855176","display_name":"Joost Boeckmans","orcid":"https://orcid.org/0000-0001-8399-5872","observed_orcids":["https://orcid.org/0000-0001-8399-5872"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Joost Boeckmans","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006591549","display_name":"Alessandra Natale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Alessandra Natale","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049617197","display_name":"Matthias Rombaut","orcid":"https://orcid.org/0000-0002-1101-1739","observed_orcids":["https://orcid.org/0000-0002-1101-1739"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Matthias Rombaut","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-1101-1739","affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065031386","display_name":"Karolien Buyl","orcid":"https://orcid.org/0000-0002-4889-9284","observed_orcids":["https://orcid.org/0000-0002-4889-9284"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Karolien Buyl","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008668373","display_name":"Vera Rogiers","orcid":"https://orcid.org/0000-0003-0635-7740","observed_orcids":["https://orcid.org/0000-0003-0635-7740"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Vera Rogiers","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030277209","display_name":"Joery De Kock","orcid":"https://orcid.org/0000-0002-4078-4896","observed_orcids":["https://orcid.org/0000-0002-4078-4896"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Joery De Kock","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-4078-4896","affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022384436","display_name":"Tamara Vanhaecke","orcid":"https://orcid.org/0000-0002-6685-7299","observed_orcids":["https://orcid.org/0000-0002-6685-7299"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Tamara Vanhaecke","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035187448","display_name":"Robim Marcelino Rodrigues","orcid":"https://orcid.org/0000-0003-2927-6791","observed_orcids":["https://orcid.org/0000-0003-2927-6791"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Robim M. Rodrigues","raw_affiliation_strings":["Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","Laarbeeklaan 103, 1090 Brussels, Belgium"],"raw_orcid":"https://orcid.org/0000-0003-2927-6791","affiliations":[{"raw_affiliation_string":"Department of In Vitro Toxicology & Dermato-Cosmetology (IVTD), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB); Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":["https://openalex.org/I13469542"]},{"raw_affiliation_string":"Laarbeeklaan 103, 1090 Brussels, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035187448"],"corresponding_institution_ids":["https://openalex.org/I13469542"],"apc_list":{"value":1800,"currency":"CHF","value_usd":1824},"apc_paid":{"value":1800,"currency":"CHF","value_usd":1824},"fwci":1.9438,"has_fulltext":true,"cited_by_count":134,"citation_normalized_percentile":{"value":0.89225352,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"9","issue":"1","first_page":"37","last_page":"37"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.8202999830245972,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.8202999830245972,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.17319999635219574,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9470000267028809},{"id":"https://openalex.org/keywords/ppar-agonists","display_name":"PPAR agonists","score":0.9229999780654907},{"id":"https://openalex.org/keywords/peroxisome-proliferator-activated-receptors","display_name":"peroxisome proliferator-activated receptors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7059999704360962},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.5630000233650208},{"id":"https://openalex.org/keywords/steatosis","display_name":"steatosis","score":0.6759999990463257},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.8889999985694885},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.7400000095367432},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.8830000162124634},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7559999823570251},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.972000002861023},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.8560818433761597},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.5822175741195679},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5546441078186035},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.4885736405849457},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.46791890263557434},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.449162095785141},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.4283735156059265},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42024707794189453},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.4118642210960388},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34019017219543457},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3243497312068939},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2982727587223053},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22157612442970276},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.11919781565666199},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07457879185676575},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005234","descriptor_name":"Fatty Liver","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047188","descriptor_name":"Chalcones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047492","descriptor_name":"Peroxisome Proliferator-Activated Receptors","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D047492","descriptor_name":"Peroxisome Proliferator-Activated Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047492","descriptor_name":"Peroxisome Proliferator-Activated Receptors","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3390/cells9010037","doi":"https://doi.org/10.3390/cells9010037","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cells9010037","pdf_url":"https://www.mdpi.com/2073-4409/9/1/37/pdf?version=1577526275","source":{"id":"https://openalex.org/S2736626452","display_name":"Cells","issn_l":"2073-4409","issn":["2073-4409"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cells","raw_type":"journal-article"},{"id":"pmid:31877771","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31877771","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cells","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7016963","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7016963/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cells","raw_type":"Text"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:126154","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/antinash-drug-development-hitches-a-lift-on-ppar-agonism(4133941f-7c45-4fa0-9f85-e6a22046a347).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/cells9010037","doi":"https://doi.org/10.3390/cells9010037","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cells9010037","pdf_url":"https://www.mdpi.com/2073-4409/9/1/37/pdf?version=1577526275","source":{"id":"https://openalex.org/S2736626452","display_name":"Cells","issn_l":"2073-4409","issn":["2073-4409"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cells","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1678743589","display_name":"Investigating the impact of PNPLA3 genetic polymorphism on the development and treatment of non-alcoholic steatohepatitis (NASH): an in vitro study using human stem cell-derived hepatic cells.","funder_award_id":"G042019N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G1695326789","display_name":null,"funder_award_id":"12H2216N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G7447687495","display_name":"Development and characterization of a human skin stem cell-derived in vitro liver model for anti-NASH drug screening.","funder_award_id":"1S10518N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"},{"id":"https://openalex.org/G8661060131","display_name":"Improve the reprogramming of human adult skin-derived fibroblasts into functional hepatocytes by directed evolution of hepatocyte nuclear factors","funder_award_id":"1S73019N","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"}],"funders":[{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2994912142.pdf","grobid_xml":"https://content.openalex.org/works/W2994912142.grobid-xml"},"referenced_works_count":142,"referenced_works":["https://openalex.org/W182006361","https://openalex.org/W1488452840","https://openalex.org/W1522960617","https://openalex.org/W1527827101","https://openalex.org/W1633340712","https://openalex.org/W1639924204","https://openalex.org/W1668919262","https://openalex.org/W1746906608","https://openalex.org/W1850330438","https://openalex.org/W1852438813","https://openalex.org/W1963683487","https://openalex.org/W1970990727","https://openalex.org/W1972175299","https://openalex.org/W1974744093","https://openalex.org/W1980237439","https://openalex.org/W1980437492","https://openalex.org/W1982920909","https://openalex.org/W1988039243","https://openalex.org/W1988123744","https://openalex.org/W1988870963","https://openalex.org/W1990055069","https://openalex.org/W2003960793","https://openalex.org/W2006755011","https://openalex.org/W2007516026","https://openalex.org/W2008404887","https://openalex.org/W2014180706","https://openalex.org/W2017511982","https://openalex.org/W2019714748","https://openalex.org/W2021000378","https://openalex.org/W2026756943","https://openalex.org/W2028616547","https://openalex.org/W2030407395","https://openalex.org/W2033514426","https://openalex.org/W2036919886","https://openalex.org/W2037467390","https://openalex.org/W2037622600","https://openalex.org/W2040119973","https://openalex.org/W2041572943","https://openalex.org/W2044431460","https://openalex.org/W2044665430","https://openalex.org/W2052931002","https://openalex.org/W2053470367","https://openalex.org/W2058294329","https://openalex.org/W2062262659","https://openalex.org/W2062761869","https://openalex.org/W2062812115","https://openalex.org/W2063518484","https://openalex.org/W2064119981","https://openalex.org/W2065624367","https://openalex.org/W2066160102","https://openalex.org/W2068367315","https://openalex.org/W2069412892","https://openalex.org/W2072362233","https://openalex.org/W2076204761","https://openalex.org/W2076604793","https://openalex.org/W2078434599","https://openalex.org/W2079907321","https://openalex.org/W2082702559","https://openalex.org/W2087701253","https://openalex.org/W2088099378","https://openalex.org/W2089320077","https://openalex.org/W2091106363","https://openalex.org/W2098591455","https://openalex.org/W2098947106","https://openalex.org/W2099966991","https://openalex.org/W2102061487","https://openalex.org/W2113328569","https://openalex.org/W2113743121","https://openalex.org/W2117727476","https://openalex.org/W2123346621","https://openalex.org/W2131980604","https://openalex.org/W2133884538","https://openalex.org/W2136354950","https://openalex.org/W2144178804","https://openalex.org/W2150748501","https://openalex.org/W2151490108","https://openalex.org/W2156050736","https://openalex.org/W2164389437","https://openalex.org/W2170075604","https://openalex.org/W2171697576","https://openalex.org/W2171971816","https://openalex.org/W2210672989","https://openalex.org/W2211572047","https://openalex.org/W2232765661","https://openalex.org/W2253420963","https://openalex.org/W2291489608","https://openalex.org/W2301340671","https://openalex.org/W2306543465","https://openalex.org/W2316193238","https://openalex.org/W2325092926","https://openalex.org/W2328023807","https://openalex.org/W2337080773","https://openalex.org/W2431581641","https://openalex.org/W2470709274","https://openalex.org/W2490682853","https://openalex.org/W2500581099","https://openalex.org/W2519479884","https://openalex.org/W2528606756","https://openalex.org/W2537033733","https://openalex.org/W2550736376","https://openalex.org/W2555612317","https://openalex.org/W2558996269","https://openalex.org/W2560504947","https://openalex.org/W2567603921","https://openalex.org/W2573090827","https://openalex.org/W2588037944","https://openalex.org/W2610791545","https://openalex.org/W2616858715","https://openalex.org/W2618863496","https://openalex.org/W2626534878","https://openalex.org/W2741416895","https://openalex.org/W2744982526","https://openalex.org/W2759997926","https://openalex.org/W2762631272","https://openalex.org/W2765263832","https://openalex.org/W2767233119","https://openalex.org/W2767801219","https://openalex.org/W2767967189","https://openalex.org/W2768977224","https://openalex.org/W2771036474","https://openalex.org/W2780927580","https://openalex.org/W2788821298","https://openalex.org/W2793564315","https://openalex.org/W2797947316","https://openalex.org/W2806597817","https://openalex.org/W2809966515","https://openalex.org/W2810423511","https://openalex.org/W2883888207","https://openalex.org/W2884913483","https://openalex.org/W2887686038","https://openalex.org/W2892733010","https://openalex.org/W2897450526","https://openalex.org/W2899595328","https://openalex.org/W2902240538","https://openalex.org/W2905500035","https://openalex.org/W2907493655","https://openalex.org/W2916395994","https://openalex.org/W2940657120","https://openalex.org/W2942023415","https://openalex.org/W2950722971","https://openalex.org/W3143409077","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W4385987388","https://openalex.org/W3041605735","https://openalex.org/W4310595451","https://openalex.org/W2775034990","https://openalex.org/W2953485865","https://openalex.org/W2102224211","https://openalex.org/W4384933844","https://openalex.org/W2589776185","https://openalex.org/W2102210313","https://openalex.org/W4384484832"],"abstract_inverted_index":{"Non-alcoholic":[0],"fatty":[1],"liver":[2,33],"disease":[3],"(NAFLD)":[4],"affects":[5],"one-third":[6],"of":[7,11,16,53,66,82,86,127,132,138,147],"the":[8,50,54,64,79,125,136,139,144,153],"population":[9],"worldwide,":[10],"which":[12,38,94],"a":[13,25,100],"substantial":[14],"number":[15],"patients":[17],"suffer":[18],"from":[19],"non-alcoholic":[20],"steatohepatitis":[21],"(NASH).":[22],"NASH":[23],"is":[24,41,45],"severe":[26],"condition":[27],"characterized":[28],"by":[29],"steatosis":[30],"and":[31,35,70,106,129,134,163,168,171],"concomitant":[32],"inflammation":[34],"fibrosis,":[36],"for":[37,63],"no":[39],"drug":[40,177],"yet":[42],"available.":[43],"NAFLD":[44],"also":[46,112,180],"generally":[47],"conceived":[48],"as":[49,115],"hepatic":[51],"manifestation":[52],"metabolic":[55],"syndrome.":[56],"Consequently,":[57],"well-established":[58],"drugs":[59,88],"that":[60,77,98],"are":[61,72,95,110,179,192],"indicated":[62],"treatment":[65],"type":[67],"2":[68],"diabetes":[69],"hyperlipidemia":[71],"thought":[73],"to":[74,186],"exert":[75],"effects":[76],"alleviate":[78],"pathological":[80],"features":[81],"NASH.":[83,148],"One":[84],"class":[85],"these":[87],"targets":[89],"peroxisome":[90],"proliferator-activated":[91],"receptors":[92,97],"(PPARs),":[93],"nuclear":[96],"play":[99],"regulatory":[101],"role":[102],"in":[103,143,159,189],"lipid":[104],"metabolism":[105],"inflammation.":[107],"Therefore,":[108],"PPARs":[109,133],"now":[111],"being":[113],"investigated":[114],"potential":[116,183],"anti-NASH":[117,176,190],"druggable":[118],"targets.":[119],"In":[120],"this":[121],"paper,":[122],"we":[123],"review":[124],"mechanisms":[126],"action":[128],"physiological":[130],"functions":[131],"discuss":[135],"position":[137],"different":[140],"PPAR":[141,154,187],"agonists":[142,155],"therapeutic":[145],"landscape":[146],"We":[149],"particularly":[150],"focus":[151],"on":[152],"currently":[156],"under":[157],"evaluation":[158],"clinical":[160],"phase":[161],"II":[162],"III":[164],"trials.":[165],"Preclinical":[166],"strategies":[167],"how":[169],"refinement":[170],"optimization":[172],"may":[173],"improve":[174],"PPAR-targeted":[175],"testing":[178],"discussed.":[181],"Finally,":[182],"caveats":[184],"related":[185],"agonism":[188],"therapy":[191],"stipulated.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2994912142","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":23},{"year":2022,"cited_by_count":27},{"year":2021,"cited_by_count":29},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-12-26T00:00:00"}
